Skip to main content

Table 1 Baseline clinical characteristics of patients with ischemic heart disease with bone marrow cells transplantation and control group without transplantation

From: Intra coronary freshly isolated bone marrow cells transplantation improve cardiac function in patients with ischemic heart disease

  IHD with BMCs-Tx(n=12) IHD without BMCs-Tx(n=12) P
Age 62 ± 6 60 ± 5 NS
m/f 8/4 9/3 NS
Cardiovascular Risk Factors (%)    
Hypertension 70 65 NS
Hyperlipidemia 60 60 NS
Smoking 80 75 NS
Diabetes 30 30 NS
Positive family history of CAD 20 15 NS
Transmural myocardial infarction, months before Tx 20 ± 8 24 ± 8 NS
No. of diseased vessels 2 ± 0.8 2 ± 0.8 NS
Infarct-related vessel (LAD/LCX/RCA) 10/0/2 9/0/3 NS
Time from symptom onset to first reperfusion therapy (hr) 6 ± 5 6 ± 4 NS
Primary reperfusion therapy (%) 100 100 NS
PTCA/Stent at the time of AMI 12/12 12/12 NS
Medication (%)    
Aspirin 100 100 NS
Clopidogrel 100 100 NS
ACE inhibitor or AT II blocker 100 100 NS
Beta-blocker 100 100 NS
Aldosterone Antagonist 25 25 NS
Statin 100 100 NS
Laboratory parameters    
CPK U/L 2010 ± 540 2145 ± 670 NS
  1. Ischemic heart disease (IHD), Bone marrow cells transplantation (BMCs-Tx), Coronary artery disease (CAD), Percutaneous transluminal coronary angioplasty (PTCA), Creatine phosphokinase (CPK), Left anterior descending coronary artery (LAD), Left circumflex artery (LCX), Right coronary artery (RCA), None significant (NS).
\